Selection of patients for percutaneous closure in nonlacunar cryptogenic stroke associated with patent foramen ovale. Data from the NORDICTUS cooperative registry

J. Tejada García,L.B. Lara Lezama, R. de la Fuente Blanco,A. Pérez de Prado,L. Benavente Fernández, M. Rico Santos,M.D. Fernández Couto,L. Naya Ríos,I. Couso Pazó, P.V. Alba, L. Redondo-Robles, L. López Mesonero,S. Arias-Rivas, M. Santamaría Cadavid,H. Tejada Meza,L. Horna Cañete, I. Azkune Calle,A. Pinedo Brochado, J.M. García Sánchez,I. Caballero Romero

Neurologia (Barcelona, Spain)(2022)

引用 0|浏览5
暂无评分
摘要
The detection of a high-risk PFO (large shunt, shunt with associated aneurysm) is the main criterion for a percutaneous closure-based therapy. Other conditions to consider in the eligibility of patients are the history of thromboembolic disease, paradoxical embolism criteria or the previous use of antithrombotics.
更多
查看译文
关键词
Stroke,Patent foramen ovale,Percutaneous closure
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要